Literature DB >> 33706221

Predictors of reoccurrence of congestive signs within 180 days after successful treatment of the first episode of congestive heart failure in dogs with myxomatous mitral valve disease.

A Franchini1, J A Abbott2, W Tyrrell3, S Rosenthal4, S Lahmers2, G Menciotti2, S Crosara5, J Häggström6, M Borgarelli2.   

Abstract

INTRODUCTION: Myxomatous mitral valve disease (MMVD) is the most common cause of left-sided congestive heart failure in dogs. We sought to identify predictors of first reoccurrence of congestive signs (CS) within 180 days in dogs with MMVD and clinically stable heart failure. ANIMALS: A total of 445 dogs affected by stable American College of Veterinary Internal Medicine (ACVIM)-Stage-C MMVD were included, 106 in the reoccurrence group (RG) and 339 in no reoccurrence group (NRG). Patients were considered "stable" if medical treatment had been unchanged for at least 4 weeks since the first identification of CS.
METHODS: Medical records of dogs with stable ACVIM-Stage-C MMVD included in a registry of dogs affected by MMVD were reviewed. Follow-up was required for inclusion in this investigation. Logistic regression was used to identify clinical and echocardiographic variables that independently predict first reoccurrence of CS.
RESULTS: Baseline left atrial-aortic ratio (p=0.022, OR: 1.89, 90% CI: 1.20-2.98), left ventricular internal diameter at end-diastole (LVIDd_N) (p=0.014, OR: 2.84, 90% CI: 1.41-5.77), peak velocity of early diastolic transmitral flow (p=0.049, OR: 1.81, 90% CI: 1.10-3.00) and furosemide daily dosage (p=0.039, OR: 1.19, 90% CI: 1.04-1.37) were associated with reoccurrence of CS in univariable analyses. The LVIDd_N (p=0.014) remained significant in the multivariable analysis, but the area under the receiver operator characteristic curve was 0.57.
CONCLUSION: This study failed to identify accurate predictors of reoccurrence of CS. However, dogs with larger value of LVIDd_N are more likely to have reoccurrence of CS within 180 days.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Canine; Degenerative valvular disease; Echocardiography; Heart failure; Valve

Year:  2021        PMID: 33706221     DOI: 10.1016/j.jvc.2020.11.005

Source DB:  PubMed          Journal:  J Vet Cardiol        ISSN: 1760-2734            Impact factor:   1.701


  3 in total

1.  Reference intervals for echocardiographic measurements in healthy Chihuahua dogs.

Authors:  Seiya Niimi; Haruna Kobayashi; Yukika Take; Shiori Ikoma; Saki Namikawa; Yoko Fujii
Journal:  J Vet Med Sci       Date:  2022-04-19       Impact factor: 1.105

2.  Performance of Different Echocardiographic Measurements of Left Atrial Size in Dogs by Observers with Different Levels of Experience.

Authors:  Alexander M Safian; Giulio Menciotti; Sunshine M Lahmers; Hyeon Jeong; Alessandra Franchini; Michele Borgarelli
Journal:  Animals (Basel)       Date:  2022-03-01       Impact factor: 2.752

3.  Influence of concurrent lower respiratory tract disease on point-of-care lung ultrasound in small-breed dogs with myxomatous mitral valve disease.

Authors:  Man-Cham Lam; Chung-Hui Lin; Pei-Ying Lo; Huey-Dong Wu
Journal:  J Vet Intern Med       Date:  2022-04-27       Impact factor: 3.175

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.